.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Obtain formulation and manufacturing information
  • Set up watchlists for daily email updates

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Julphar
Deloitte
Queensland Health
McKesson
Fuji
Boehringer Ingelheim
Teva
Medtronic
Chubb
Express Scripts

Generated: June 23, 2017

DrugPatentWatch Database Preview

TERBUTALINE SULFATE Drug Profile

« Back to Dashboard

Which patents cover Terbutaline Sulfate, and what generic Terbutaline Sulfate alternatives are available?

Terbutaline Sulfate is a drug marketed by United Biomedcl, Hikma Farmaceutica, Akorn, Lannett, Teva Pharms Usa, Athenex Inc, Impax Labs, and Fresenius Kabi Usa. and is included in eight NDAs.

The generic ingredient in TERBUTALINE SULFATE is terbutaline sulfate. There are seven drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the terbutaline sulfate profile page.

Summary for Tradename: TERBUTALINE SULFATE

Patents:0
Applicants:8
NDAs:8
Suppliers / Packagers: see list13
Bulk Api Vendors: see list67
Clinical Trials: see list658
Patent Applications: see list3,379
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:TERBUTALINE SULFATE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
United Biomedcl
TERBUTALINE SULFATE
terbutaline sulfate
INJECTABLE;INJECTION200122-001Nov 8, 2013APRXNoNo► Subscribe► Subscribe
Athenex Inc
TERBUTALINE SULFATE
terbutaline sulfate
INJECTABLE;INJECTION076770-001Apr 23, 2004APRXNoYes► Subscribe► Subscribe
Lannett
TERBUTALINE SULFATE
terbutaline sulfate
TABLET;ORAL077152-001Mar 25, 2005RXNoNo► Subscribe► Subscribe
Impax Labs
TERBUTALINE SULFATE
terbutaline sulfate
TABLET;ORAL075877-001Jun 26, 2001DISCNNoNo► Subscribe► Subscribe
Hikma Farmaceutica
TERBUTALINE SULFATE
terbutaline sulfate
INJECTABLE;INJECTION078630-001May 20, 2009APRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
Deloitte
Chinese Patent Office
Argus Health
Mallinckrodt
US Department of Justice
Baxter
Boehringer Ingelheim
AstraZeneca
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot